Literature DB >> 2983117

Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera.

J M Middeldorp, J Jongsma, T H The.   

Abstract

Using indirect immunofluorescence and a panel of human convalescent-phase sera, we identified cytomegalovirus (CMV) early and late membrane antigens (CMV-EMA and CMV-LMA, respectively) as separate entities on the surfaces of viable CMV-infected fibroblasts starting at 6 to 12 and 36 to 48 h postinoculation, respectively. For expression of CMV-EMA and CMV-LMA, infectious virus and active protein synthesis were required, whereas the expression of CMV-LMA, in addition, required viral DNA synthesis. Our data suggest that CMV-EMA and CMV-LMA form an individual set of CMV antigens that are different from intracellular CMV antigens and possibly (partly) different from the viral envelope.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983117      PMCID: PMC254785     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Membrane glycoproteins and antigens induced by human cytomegalovirus.

Authors:  M F Stinski; E S Mocarski; D R Thomsen; M L Urbanowski
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

2.  Cytomegalovirus-induced membrane antigens in productively infected cells.

Authors:  I Boldogh; E Gönczöl; L Váczi
Journal:  Acta Microbiol Acad Sci Hung       Date:  1977

3.  Immediate early antigens in human cytomegalovirus infected cells.

Authors:  S Michelson-Fiske; F Horodniceanu; J C Guillon
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

4.  Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. I. Sequence of viral replication.

Authors:  J D Smith; E De Harven
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

5.  Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method.

Authors:  T H The; T E Feltkamp
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

6.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

Authors:  J M Middeldorp; J Jongsma; A ter Haar; J Schirm; T H The
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

7.  Cytomegalovirus: development and progression of cytopathic effects in human cell culture.

Authors:  T Albrecht; T Cavallo; N L Cole; K Graves
Journal:  Lab Invest       Date:  1980-01       Impact factor: 5.662

8.  Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test.

Authors:  C H Ten Napel; T H The; J Bijker; G C De Gast; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

9.  Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.

Authors:  T H The; G Klein; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

10.  Inhibition of cytomegalovirus late antigens by phosphonoformate.

Authors:  B Wahren; B Oberg
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

View more
  3 in total

1.  Changes in membrane permeability in cells infected by human cytomegalovirus.

Authors:  M Rugolo; B Baldassarri; M P Landini
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens.

Authors:  J M Middeldorp; J Jongsma; T H The
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

3.  Characterization of membrane antigens on human cytomegalovirus-infected fibroblasts recognized by human antibodies.

Authors:  L H van der Voort; L F de Leij; T H The
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.